Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730652 | SCV000858404 | uncertain significance | not provided | 2017-11-28 | criteria provided, single submitter | clinical testing | |
Laboratory of Cyto- |
RCV001843546 | SCV002102795 | likely pathogenic | Fanconi renotubular syndrome 3 | 2022-03-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003392568 | SCV004119574 | uncertain significance | EHHADH-related disorder | 2023-03-15 | criteria provided, single submitter | clinical testing | The EHHADH c.673C>G variant is predicted to result in the amino acid substitution p.Pro225Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0028% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-184922441-G-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |